[1] |
Shi Jin, Chengyin Li, Xinyue Jing, Yunru Peng, Shaohua Dong, Wanjin Sun.
Study on quality control of Xiaozhong Ointment NO. 1 based on the relationship between quality fractions of main components in monarch and minister drugs and the clinical efficacy
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 764-771.
|
[2] |
Yancong Zhao, Li Wang, Jingjing Zeng, Jinghua Li.
The structure and antiproliferative activity of the inclusion complex of neoandrographolide/β-cyclodextrin
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(6): 427-434.
|
[3] |
Yancong Zhao, Huiyuan Gong, Jinghua Li.
Overexpression of hBD3 inhibits cell proliferation, cell cycle, and migration in colon cancer cells
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 250-259.
|
[4] |
Meiqi Gao, Jiali Wu, Wenjing Zhu, Xiaotong Zhang, Wenling Fan.
The preparation and characterization of sustained-release solid dispersion of resveratrol by hot-melt extrusion technology
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 165-179.
|
[5] |
Xinfeng Zou, Haihua Guo, Liangjun Deng, Yuting Yang, Zhengqiang Yuan, Wen Tan.
A study of irritable bowel syndrome model construction based on combined factor stimulation
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 180-189.
|
[6] |
Limei Yang, Liman Wang, Xuhui Huang, Jie Zhuang.
Warfarin affects the proliferation and apoptosis of lung cancer cells by regulating the Gas6/Axl/PI3K/Akt/NF-κB pathway
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 190-199.
|
[7] |
Jianzhao Niu, Dongsheng Yang, Yufei Feng, Baihao Sun, Haoyue Guan, Lingyun Ma.
The introduction of nitrosamine impurities in medicinal products
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 223-230.
|
[8] |
Daiying Zhou, Jing Chen, Zhigang Lv.
Network pharmacology prediction and molecular docking-based study on the mechanism of Erigeron breviscapus in the treatment of age-related macular degeneratio
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 923-934.
|
[9] |
Yongyuan Li, Maomei Xie, Chen Chen, Youqing Wen, Yueling Yan, Haixia Wang.
Preparation of two sustained-release formulations of andrographolide by semi-solid extrusion 3D printer
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 935-946.
|
[10] |
Xinyu Chang, Lijuan Han, Yang Liu, Zheng Fan, Jiankun Wu.
Analysis of adverse drug reactions caused by carbapenems and review of related literature
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(10): 835-841.
|
[11] |
Rui Li, Xiangyu Xu, Di Chen, Yue Zhang, Haonan Qian, Genao Zang, Guangrong Yan, Tianyuan Fan.
Fused deposition modeling 3D printed oral famotidine pulsatile release tablets
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 657-664.
|
[12] |
Feng Zhao, Rui Wang, Hongxiong Zhang, Taixiang Gao, Nan Wang.
Pharmacodynamics of Yuebi Jiazhu Decoction on renal protection of adriamycin nephropathy rats
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 711-717.
|
[13] |
Ye Yuan, Bo Yu, Zhenzhen Yang, Weichong Dong, Xiuling Yang.
Pharmacological monitoring and literature analysis of dagliflozin in patients with hypovolemia
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 718-722.
|
[14] |
Jie Yang, Haiyang Meng, Duolu Li, Yanying Wang, Zhaosen Gu, Xiaojian Zhang.
Drug-related problems among inpatients of integrated traditional Chinese and western medicine department in China
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(4): 279-288.
|
[15] |
Liangyu Liu, Yuke Yang, Xiao Du, Tong Wu, Jiannong Wang.
Three previously undescribed steroidal glycoalkaloids from Solanum lyratum and their anti-tumor activities
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(3): 192-201.
|